Other,clinicalStudies
Other,She
Other,youngPatients
Other,index
Other,screeningBehavior
Other,excision
Other,FilipinoWomen
Other,scanTime
Other,novelTargetedTherapeuticOptions
Other,novelTechnique
Other,BACKGROUND
Other,results
Other,hormonalContraceptionUse
Other,18F-FDGPET/CTImages
Other,intake
Other,strongIndependentPrognosticFactor
Other,novelTherapeuticOptions
Other,selectedCases
Other,betterOutcome
Other,tumorDetectability
Other,components
Other,imagesneed
Other,we
Other,longScanTime
Other,cohortStudy
Other,agreement
Other,contrastAgents
Other,third-degree
Other,smallMoleculeInhibitors
Other,appropriateness
Other,theResulting
Other,powerfulTechnique
Other,breastExamination
Other,CXCR4-directedPETImaging
Other,Metastases
Other,complexDisease
Other,definitiveDiagnosis
Other,Anthracyclines
Other,Aims
Other,amount
Other,theirEmergingRole
Other,performance
Other,analysis
Other,Osteopontin-750Accumulation
Other,CXCR4-targetedPETImaging
Other,allotting
Other,unenhancedMRITechniques
Other,osteopontin-basedProbe
Other,p
Other,SeromaFormation
Other,article
Other,therapeuticOptions
Other,BetterUnderstanding
Other,cTnLevels
Other,relationship
Other,moreSpecificApplications
Other,homologousRecombinationPathway
Other,address
Other,signature
Other,HealthcarePolicyMakers
Other,dose-dependentReduction
Other,CoxProportionalHazardRegressionModels
Other,cancerRiskPerception
Other,largerProspectiveStudies
Other,initialResults
Other,rareClinicalEntity
Other,doses
Other,search
Other,screeningMammography
Other,fourPatients
Other,OurFindings
Other,probe
Other,Information
Other,imagingProtocol
Other,symptomControl
Other,theirAbility
Other,tumor-to-backgroundRatios
Other,radicalSurgicalApproaches
Other,contrast-enhancedScreeningTools
Other,differentialDiagnosis
Other,recentDanishCohortStudy
Other,imagingTechnique
Other,MedianAmount
Other,24ApplicableCases
Other,breastImagingModality
Other,TenStudies
Other,ManyFeatures
Other,They
Other,lowCTnLevels
Other,cardiotoxicityDiagnosis
Other,evaluation
Other,targetedTherapeuticOptions
Other,images
Other,importantCornerstone
Other,summaryHazardRatios
Other,comprehensiveSearch
Other,highIndex
Other,significantAdvances
Other,surgicalExcision
Other,targetedOptions
Other,she
Other,novelTargetedOptions
Other,Ulceration
Other,alternativeScreeningTools
Other,they
Other,We
Other,increase
Other,Forty-threeCases
Other,BRD4Regulation
Other,disease
Other,IORT
Other,biomarker
Other,SimilarTowaveletFilter
Other,membraneTypeMR
Other,understanding
Other,581Patients
Other,discovery
Other,options
Other,recombinationPathway
Other,Mammography
Other,Radiotherapy
Other,locoregionalRadiotherapy
Other,role
Other,elderlyPatient
Other,treatment
Other,contraceptionUse
Other,postmenopausalPatient
Other,multiresolutionResult
Other,RESULTS
Other,radiotherapy
Other,membraneTypeMannoseReceptor
Other,identification
Other,primaryTumour
Other,novelPowerfulTechnique
Other,40
Other,collectedSignatures
Other,novelOptions
Other,cornerstone
Other,ObservationalStudies
Other,troponins
Other,Extra-TerminalBETProteins
Other,bleeding
Other,mutations
Other,MRI
Other,technique
Other,differentStudies
Other,FemalePatients
Other,strongAssociation
Other,five
Other,largerStudies
Other,case
Other,highCosts
Other,lesion
Other,costs
Other,12SampledWomen
Other,FurtherDevelopment
Other,studies
Other,neuroma
Other,95%ConfidenceIntervals
Other,I2
Other,it
Other,ConservativeTreatment
Other,HerPresentation
Other,observedVariation
Other,directRelationship
Other,prospectiveStudies
Other,screeningTools
Other,Comparison
Other,anti-HER2Therapy
Other,Efforts
Other,CardiacTroponins
Other,MedianFollow-up
Other,herDisease
Other,Diagnosis
Other,association
Other,result
Other,%
Other,466%
Other,towaveletFilter
Other,alternativeContrast-enhancedScreeningTools
Other,%ConfidenceIntervals
Other,theirInhibition
Other,MedianAge
Other,X-rayMammography
Other,study
Other,time
Other,mammographicImages
Other,diagnosticPerformance
Other,numerousGene-expression-basedSignatures
Other,research
Other,MRITechniques
Other,aim
Other,the
Other,mostPatients
Other,infraredFluorescentImaging
Other,familialCancerClustering
Other,onePatient
Other,most
Other,reproducibilityStudies
Other,prognosticSignatures
Other,24Cases
Other,subcutaneousBreastTumor
Other,Anti-HER2Therapies
Other,breastCancerEffects
Other,decreases
Other,glycosylationSites
Other,necessity
Other,ImprovedDetection
Other,currentDevelopments
Other,DiagnosticEvaluation
Other,strongContrast
Other,FluorescenceImagingExVivo
Other,markedReduction
Other,OurLiteratureReview
Other,increasedRisk
Other,respondents
Other,BETProteins
Other,standardizedImagingProtocol
Other,risk
Other,heterogeneousCancer
Other,DanishCohortStudy
Other,barcodeMode
Other,clinicians
Other,TraumaticNeuroma
Other,TraumaticBreastNeuromas
Other,follow-up
Other,signatures
Other,gene-expression-basedPrognosticSignatures
Other,numerousGene-expression-basedPrognosticSignatures
Other,MSOTImaging
Other,deterioration
Other,longTime
Other,numerousPrognosticSignatures
Other,subtype-specificSignature
Other,breastNeuromas
Other,higher
Other,ThirteenPatients
Other,features
Other,theirCardiotoxicities
Other,MRIProtocols
Other,traumaticNeuroma
Other,imagingFeatures
Other,development
Other,diagnosis
Other,update
Other,numerousSignatures
Other,availableContrastAgents
Other,gene-expression-basedSignatures
Other,improvedBreastCancerOS
Other,cases
Other,1
Other,detection
Other,CoxHazardRegressionModels
Other,repair
Other,signalIntensity
Other,use
Other,SelectiveBinding
Other,subjectiveRisk
Other,binding
Other,Bromodomain
Other,12-15%
Other,involved
Other,retrospectiveAnalysis
Other,ConventionalX-rayMammography
Other,BRD4PharmacologicalInhibition
Other,higherSUVmax
Other,PETImaging
Other,Breast
Other,exhibiting
Other,adjustment
Other,1062Patients
Other,FurtherResearch
Other,breast
Other,detectionofBreastCancer
Other,recentCohortStudy
Other,commonCancer
Other,BRCAnessPhenotype
Other,routineClinicalBiomarker
Other,Transcripts
Other,higherResolution
Other,age
Other,moleculeInhibitors
Other,PatientDemographics
Other,prolongedRecovery
Other,experiences
Other,segmentationAlgorithm
Other,metastaticDisease
Other,BRD4Inhibition
Other,response
Other,pharmacologicalInduction
Other,cTn
Other,SixGlycosylationSites
Other,clinicalBreastExamination